Delivery Order V797P5878X-V501D70057

The Defense Logistics Agency awarded a delivery order valued at $49,259.33 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant commonly used to treat rheumatoid arthritis,...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,093,165 units of Enbrel 50 mg/ml syringe, a medication used to treat autoimmune disorders. The contract has a ceiling value of $4,787.86 and a period of performance through May 1, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial...

The Defense Logistics Agency awarded a $4,626.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 18, 2025. ENBREL (etanercept) is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions, representing a critical pharmaceutical commodity for military and federal healthcare...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of ENBREL 50 MG/ML SYRINGE, a specialty pharmaceutical product, with a ceiling value of $15,227.16 and a period of performance through April 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and parent company...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $14,527.48 and a performance period ending on June 18, 2025. The award is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of ENBREL 50 MG/ML SYRINGE, a specialty pharmaceutical product, with a potential value of $10,552.40. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....

The Defense Logistics Agency awarded a $35,136.89 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML SURECLICKML. The prime contractor will deliver the biologic drug from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were identified. ENBREL is an injectable medication used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque...

The Defense Logistics Agency awarded a $40,735.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 3, 2025. This non-set-aside award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions,...

AmerisourceBergen Drug Corp has been awarded a delivery order for ENBREL 50 mg/ml SureClick auto-injectors valued at $24,517.71 by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 9, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a TNF inhibitor used to treat...

This is a $4,952.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a medication used to treat certain medical conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...